| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6064212 | Journal of Allergy and Clinical Immunology | 2015 | 15 Pages |
Abstract
Ex vivo-generated HuMoSCs inhibit effector T lymphocytes, promote the expansion of immunosuppressive forkhead box protein 3-positive CD8+ regulatory T cells, and can be used as an efficient therapeutic tool to prevent GvHD.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Nona PhD, Malika PhD, Alexandrine MS, Maxime MD, Baptiste MS, Francis PhD, Stéphanie PhD, Marion BS, Khatuna MS, Famky MS, Béatrice PhD, Sylvain PhD, Andrew MD, PhD, Laurent MD, PhD, Sylvain MD, PhD, Philippe PhD, Nicolas PhD, Bernard MD, PhD,